- United States
- /
- Medical Equipment
- /
- NasdaqCM:EKSO
Ekso Bionics Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Ekso Bionics Holdings (NASDAQ:EKSO) Third Quarter 2024 Results
Key Financial Results
- Revenue: US$4.13m (down 10% from 3Q 2023).
- Net loss: US$2.07m (loss narrowed by 38% from 3Q 2023).
- US$0.10 loss per share (improved from US$0.24 loss in 3Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ekso Bionics Holdings EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 26%. Earnings per share (EPS) exceeded analyst estimates by 4.8%.
Looking ahead, revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 7.7% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Ekso Bionics Holdings (2 can't be ignored) you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Ekso Bionics Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:EKSO
Ekso Bionics Holdings
Designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
High growth potential with adequate balance sheet.